Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Botox versus Placebo for Treatment of Patients with Major Depression
TCTR20170409001Phase 1Recruiting
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in major depressive disorder (MDD) comparing Botox with Placebo (2 arms). Started Apr 2017; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on TCTR20170409001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170409001.